Cargando…
Evidence against PALB2 involvement in Icelandic breast cancer susceptibility
Several mutations in the PALB2 gene (partner and localizer of BRCA2) have been associated with an increased risk of breast cancer, including a founder mutation, 1592delT, reported in Finnish breast cancer families. Although most often the risk is moderate, it doesn't exclude families with high-...
Autores principales: | Gunnarsson, Haukur, Arason, Adalgeir, Gillanders, Elizabeth M, Agnarsson, Bjarni A, Johannesdottir, Gudrun, Johannsson, Oskar Th, Barkardottir, Rosa B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491591/ https://www.ncbi.nlm.nih.gov/pubmed/18637200 http://dx.doi.org/10.1186/1477-5751-7-5 |
Ejemplares similares
-
The BRCA1 c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic BRCA1 Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows Homozygous Viability
por: Arason, Adalgeir, et al.
Publicado: (2019) -
Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families
por: Arason, Adalgeir, et al.
Publicado: (2010) -
The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients
por: Gudmundsdottir, Eydis Th, et al.
Publicado: (2012) -
High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer
por: Staaf, Johan, et al.
Publicado: (2010) -
High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer
por: Reynisdottir, Inga, et al.
Publicado: (2013)